The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients

Infection, Genetics and Evolution

Volumn 21, Issue , 2014, Pages

  Ezzikouri, Sayeh ^a   Alaoui, Rhimou ^b   Tazi, Sana ^a   Nadir, Salwa ^b   Elmdaghri, Naima ^a   Pineau, Pascal ^c   Benjelloun, Soumaya ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^c INSTITUT PASTEUR   (France)

Author keywords

Genetic marker; Hepatocellular carcinoma; PNPLA3; Spontaneous clearance

Indexed keywords

ADIPONUTRIN; CYTOKINE; PEGINTERFERON ALPHA; RIBAVIRIN; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

ADULT; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORTH AFRICA; PNPLA GENE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; AGED; CARCINOMA, HEPATOCELLULAR; COMPLICATION; EPIDEMIOLOGY; GENETICS; HEPADNAVIRIDAE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MOROCCO; PHYSIOLOGY; RISK FACTOR; VIROLOGY;

HEPATITIS C VIRUS;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE FREQUENCY; GENOTYPE; HEPADNAVIRIDAE; HUMANS; LIPASE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOROCCO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84889603618     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.11.005     Document Type: Article

References (37)

1. Asselah T., Rubbia-Brandt L., Marcellin P., Negro F. Steatosis in chronic hepatitis C: why does it really matter?. Gut 2006, 55:123-130.
2. Bahri O., Ezzikouri S., Alaya-Bouafif N.B., Iguer F., Feydi A.E., Mestiri H., Benazzouz M., Khalfallah T., Afifi R., Elkihal L., Berkane S., Marchio A., Debzi N., Dejean A., Pineau P., Triki H., Benjelloun S. First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J. Hepatol. 2011, 3:24-30.
3. Batnitzky A. Obesity and household roles: gender and social class in Morocco. Sociol. Health Illn. 2008, 30:445-462.
4. Belahsen R., Mziwira M., Fertat F. Anthropometry of women of childbearing age in Morocco: body composition and prevalence of overweight and obesity. Public Health Nutrition 2004, 7:523-530.
5. Benjelloun S. Nutrition transition in Morocco. Public health nutrition 2002, 5:135-140.
6. Brahim I., Akil A., Mtairag el M., Pouillot R., Malki A.E., Nadir S., Alaoui R., Njouom R., Pineau P., Ezzikouri S., Benjelloun S. Morocco underwent a drift of circulating hepatitis C virus subtypes in recent decades. Arch. Virol. 2012, 157:515-520.
7. Burza M.A., Pirazzi C., Maglio C., Sjoholm K., Mancina R.M., Svensson P.A., Jacobson P., Adiels M., Baroni M.G., Boren J., Ginanni Corradini S., Montalcini T., Sjostrom L., Carlsson L.M., Romeo S. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals. Dig. Liver Dis. 2012, 44:1037-1041.
8. Chen S.L., Morgan T.R. The natural history of hepatitis C virus (HCV) infection. Int. J. Med. Sci. 2006, 3:47-52.
9. Corradini S.G., Burza M.A., Molinaro A., Romeo S. Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma. Hepatology 2011, 53:1776. author reply 1777.
10. Coudray C., Guitard E., Kandil M., Harich N., Melhaoui M., Baali A., Sevin A., Moral P., Dugoujon J.M. Study of GM immunoglobulin allotypic system in Berbers and Arabs from Morocco. Am. J. Hum. Biol. 2006, 18:23-34.
11. Ezzikouri S., El Feydi A.E., Chafik A., Afifi R., El Kihal L., Benazzouz M., Hassar M., Pineau P., Benjelloun S. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients. Mutat. Res. 2008, 649:1-6.
12. Falleti E., Fabris C., Cmet S., Cussigh A., Bitetto D., Fontanini E., Fornasiere E., Bignulin S., Fumolo E., Bignulin E., Pirisi M., Toniutto P. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int. 2011, 31:1137-1143.
13. Guyot E., Sutton A., Rufat P., Laguillier C., Mansouri A., Moreau R., Ganne-Carrie N., Beaugrand M., Charnaux N., Trinchet J.C., Nahon P. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. J. Hepatol. 2013, 58:312-318.
14. He S., McPhaul C., Li J.Z., Garuti R., Kinch L., Grishin N.V., Cohen J.C., Hobbs H.H. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 2010, 285:6706-6715.
15. Holdsworth M., El Ati J., Bour A., Kameli Y., Derouiche A., Millstone E., Delpeuch F. Developing national obesity policy in middle-income countries: a case study from North Africa. Health policy plan. 2012, 10:1-13.
16. Hsu C.S., Huang C.J., Kao J.H., Lin H.H., Chao Y.C., Fan Y.C., Tsai P.S. Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients. PloS one 2013, 8:e70458.
17. Jaouad I.C., Elalaoui S.C., Sbiti A., Elkerh F., Belmahi L., Sefiani A. Consanguineous marriages in Morocco and the consequence for the incidence of autosomal recessive disorders. J. Biosoc. Sci. 2009, 41:575-581.
18. Jenkins C.M., Mancuso D.J., Yan W., Sims H.F., Gibson B., Gross R.W. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J. Biol. Chem. 2004, 279:48968-48975.
19. Laamiri F.Z., Otmani A., Ahid S., Barkat A. Lipid profile among Moroccan overweight women and breast cancer: a case-control study. Int. J. Gen. Med. 2013, 6:439-445.
20. Marzouk D., Sass J., Bakr I., El Hosseiny M., Abdel-Hamid M., Rekacewicz C., Chaturvedi N., Mohamed M.K., Fontanet A. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut 2007, 56:1105-1110.
21. Monazahian M., Bohme I., Bonk S., Koch A., Scholz C., Grethe S., Thomssen R. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 1999, 57:223-229.
22. Morgan R.L., Baack B., Smith B.D., Yartel A., Pitasi M., Falck-Ytter Y. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Annals of internal medicine 2013, 158:329-337.
23. Nischalke H.D., Berger C., Luda C., Berg T., Muller T., Grunhage F., Lammert F., Coenen M., Kramer B., Korner C., Vidovic N., Oldenburg J., Nattermann J., Sauerbruch T., Spengler U. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS One 2011, 6:e27087.
24. Okuda M., Li K., Beard M.R., Showalter L.A., Scholle F., Lemon S.M., Weinman S.A. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002, 122:366-375.
25. Rafi H., Kabbaj N., Salihoun M., Amrani L., Acharki M., Guedira M., Nya M., Amrani N. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases. Arab J. Gastroenterol. 2011, 12:136-138.
26. Rguibi M., Belahsen R. Overweight and obesity among urban Sahraoui women of South Morocco. Ethn. Dis. 2004, 14:542-547.
27. Romeo S., Kozlitina J., Xing C., Pertsemlidis A., Cox D., Pennacchio L.A., Boerwinkle E., Cohen J.C., Hobbs H.H. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 2008, 40:1461-1465.
28. Ryder S. Do high lipids help clearance of hepatitis C?. Gut 2007, 56:1044-1045.
29. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 2005, 5:558-567.
30. Sookoian S., Pirola C.J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011, 53:1883-1894.
31. Thomas D.L., Seeff L.B. Natural history of hepatitis C. Clin. Liver Dis. 2005, 9:383-398. vi.
32. Trepo E., Guyot E., Ganne-Carrie N., Degre D., Gustot T., Franchimont D., Sutton A., Nahon P., Moreno C. PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis. Hepatology 2012, 55:1307-1308.
33. Valenti L., Aghemo A., Stattermayer A.F., Maggioni P., De Nicola S., Motta B.M., Rumi M.G., Dongiovanni P., Ferenci P., Colombo M., Fargion S. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Aliment. Pharmacol. Ther. 2012, 35:1434-1442.
34. Valenti L., Al-Serri A., Daly A.K., Galmozzi E., Rametta R., Dongiovanni P., Nobili V., Mozzi E., Roviaro G., Vanni E., Bugianesi E., Maggioni M., Fracanzani A.L., Fargion S., Day C.P. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010, 51:1209-1217.
35. Valenti L., Alisi A., Nobili V. I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology. Hepatology 2012, 56:1883-1889.
36. Valenti L., Rumi M., Galmozzi E., Aghemo A., Del Menico B., De Nicola S., Dongiovanni P., Maggioni M., Fracanzani A.L., Rametta R., Colombo M., Fargion S. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology 2011, 53:791-799.
37. Wu J.M., Skill N.J., Maluccio M.A. Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma. HPB 2010, 12:625-636.